Cargando…
Tumor growth inhibition modeling of individual lesion dynamics and interorgan variability in HER2‐negative breast cancer patients treated with docetaxel
Information on individual lesion dynamics and organ location are often ignored in pharmacometric modeling analyses of tumor response. Typically, the sum of their longest diameters is utilized. Herein, a tumor growth inhibition model was developed for describing the individual lesion time‐course data...
Autores principales: | Krishnan, Sreenath M., Laarif, Sofiene S., Bender, Brendan C., Quartino, Angelica L., Friberg, Lena E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129720/ https://www.ncbi.nlm.nih.gov/pubmed/33818899 http://dx.doi.org/10.1002/psp4.12629 |
Ejemplares similares
-
Multistate model for pharmacometric analyses of overall survival in HER2‐negative breast cancer patients treated with docetaxel
por: Krishnan, Sreenath M., et al.
Publicado: (2021) -
Mediators of Interorgan Crosstalk in Metabolic Inflammation
por: Collino, Massimo, et al.
Publicado: (2013) -
Multifaceted roles of pericytes-interorgan interactions
por: Zheng, Zhitong, et al.
Publicado: (2020) -
Bone circuitry and interorgan skeletal crosstalk
por: Zaidi, Mone, et al.
Publicado: (2023) -
Interorgan Crosstalk Contributing to β-Cell Dysfunction
por: Tanabe, Katsuya, et al.
Publicado: (2017)